Dear Editor, Congenital syphilis, an outcome of maternal syphilis, occurs either due to transplacental transmission of Treponema pallidum in utero or through contact with an infectious genital lesion during delivery. A severe and disabling infection, it is associated with miscarriage, stillbirths and neonatal deaths, foetal abnormalities and prematurity. [1] Live neonates develop either an early symptomatic disease or may be asymptomatic at birth developing serious sequelae later. In the recent years, due to improved medical care, congenital syphilis has become a comparative rarity. However, slight resurgence of the entity can be observed from time to time in both developed and newly industrialised countries. [2, 3] The disease still continues to affect pregnant women, resulting in considerable perinatal morbidity and mortality. Globally, just over 2 million pregnant women test positive for syphilis each year, comprising 1.5% of all pregnancies worldwide and resulting in 692,100-1.53 million adverse pregnancy outcomes including 650,000 perinatal deaths. [4, 5] Thus, despite the fact that congenital syphilis can be detected and treated successfully, it continues to be a serious healthcare problem, particularly in developing nations. We report here a case of congenital syphilis in a premature infant to highlight and emphasise the continuing scourge of this serious, yet preventable disease.
A male baby born by spontaneous vaginal delivery to a 33-year-old primigravida mother at 31 weeks of gestation with a birth weight of 1400 g presented on day 1 with respiratory distress and paucity of movements of all limbs. The baby was immediately admitted to the Neonatal Intensive Care Unit because of prematurity and respiratory distress. Born at a community health centre (CHC), the baby was referred to our hospital because of the onset of respiratory distress soon after birth, which could not be managed at the CHC.
The infant's vital signs on admission were as follows: Temperature 33.9°C, heart rate 120/min, respiratory rate 66/min and SpO 2 38%. On physical examination, the baby appeared cyanotic and limp, with a capillary refill time of 3 s and had shallow respiratory efforts. There were no other relevant positive clinical findings. Hence, immediately, the baby was put on nasal continuous positive airway pressure (CPAP) support. Complete blood count of the baby including haemoglobin (131 g/L), platelet count (2.4 × 10 9 /L) and red cell count (4.4 × 10 6 /L) were within normal limits, except for the white blood cell count that showed leucocytosis (20.3 × 10 9 /L with 68% neutrophils, 26% lymphocytes and 4% monocytes). Random blood sugar level (54 mg/dL) was normal. On further examination, sepsis screen was found to be negative. Long bone radiography revealed no bony changes. However, chest X-ray revealed fluid in interlobar fissure (right) and streaky opacities radiating from hilum, suggestive of transient tachypnoea of the newborn. It was found that the mother had attended CHC for antenatal care (ANC) irregularly and she reported an uneventful antenatal period. However, no serological screening reports were available. Hence, as part of routine protocol, maternal samples were sent for serology. Tests for human immunodeficiency virus (HIV) and hepatitis B were non-reactive, but rapid plasma reagin (RPR) (Beacon Diagnostics Pvt. Ltd., Navsari, India) test was reactive at a dilution of 1:8 [ Figure 1a ]. Hence, blood sample from the baby was also sent for relevant investigations which showed toxoplasma immunoglobulin M to be negative and tests for HIV and hepatitis B to be non-reactive. However, RPR was reactive for the infant at a dilution of 1:16 [ Figure 1b ]. The father also had reactive RPR test at a dilution of 1:8 without clinical manifestations of syphilis. The T. pallidum haemagglutination test was positive in the baby, mother and father. Cerebrospinal fluid (CSF) study was within normal limit and CSF RPR was also negative. Fundoscopy was normal. The baby was diagnosed as a case of congenital syphilis and was treated with single intramuscular (IM) benzathine penicillin G (1.2 million units) as aqueous crystalline penicillin G was not available in the local market. Improvement in respiratory status was noted within 48 h of initiating treatment along with improvement in muscle tone. The baby was off CPAP on day 2. Both the parents were diagnosed as latent syphilis of unknown duration and were administered benzathine penicillin G 7.2 million units totally, administered as three doses of 2.4 million units IM each at 1-week intervals. The baby was discharged on the 26 th day of admission with advice to follow up at 3 and 6 months.
Congenital syphilis should have ceased to occur long back, in view of the availability of cost-effective preventive measures in the form of screening tests and the availability of a cheap and effective treatment in the form of benzathine penicillin to which the causative organism is still extremely sensitive. In fact, the programme data from National AIDS Control Organization show a declining trend of seropositivity of syphilis among ANC attendees at designated sexually transmitted infections/reproductive tract infections clinics, from 1.7% in 2005-2006 to 0.8% since 2010-2011, [6] highlighting improved awareness and expanded implementation of ANC services for screening of maternal syphilis. In 2007, the World Health Organization launched a global initiative to eliminate mother-to-child transmission of syphilis by the year 2015 and developed strategies to combat the disease, including strong political will, improved access to ANC, screening and treatment and surveillance system. [7] Despite implementation of the initiative, a total of 103,960 pregnant women with probable active syphilis were estimated to occur in India, resulting in an estimated 53,187 adverse outcomes during the year 2012 alone. [8] Further, it was observed that, despite 90% of pregnant women having attended at least one ANC visit, more than 90% of women were not screened for syphilis and only half of all seropositive women were treated, indicating a low uptake of maternal syphilis screening and treatment in India. [8] In tune with the study by Chen et al., [8] a recent global study also reports that most syphilis-induced pregnancy outcomes were in women who attended ANC, suggesting that these poor outcomes could have been prevented had recommended testing and treatment been done. [1] In the current case also, though the mother had attended ANC, she was neither screened nor treated for syphilis, resulting in transmission of infection to the fetus. Thus, in spite of improvements in access to ANC, ensuring that women are screened for syphilis and that infected women are treated continues to be a challenge because of low awareness among providers and clients and the poor provision capacities in many resource-limited areas.
Syphilis is among the top causes of preventable stillbirths; hence, elimination of congenital syphilis constitutes one of the topmost priorities as part of the response to end preventable stillbirths by 2030. [9] Since untreated maternal syphilis remains a substantial cause of preventable perinatal morbidity and mortality, intensified efforts for detection of maternal syphilis during ANC visits and achieving a drastic reduction in the number of untreated maternal syphilis cases is of paramount importance. It is also crucial to implement the Centres for Disease Control and Prevention recommendation that all the pregnant women should be screened for syphilis in the first antenatal visit in the first trimester and again in late pregnancy and at birth.
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